Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk
NCT ID: NCT02624271
Last Updated: 2023-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2000 participants
INTERVENTIONAL
2016-08-04
2019-05-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thus, the aim of this project is to investigate the possible screening of gastric precancerous lesions by a blood test (GastroPanel®) in France, in patients with oesophagogastroduodenoscopy (EGD) prescription.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atrophic Gastritis Predicts the Risk of Gastric Cancer
NCT06203327
Blood Tests for Gastritis and Gastric Neoplasms
NCT05883345
Gastropanel for Gastric Atrophy and Cancer Risk Assessment
NCT02114411
Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication
NCT01678027
Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer
NCT04989153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GastroPanel
GastroPanel test on blood samples
blood samples analysis
Analyze blood samples with GastroPanel test to detect gastric precancerous lesions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood samples analysis
Analyze blood samples with GastroPanel test to detect gastric precancerous lesions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with increased risk of gastric cancer (at least one of the following criteria):
* age \> 50 years,
* family cases of gastric cancer,
* known precancerous lesions,
* Biermer disease,
* H. Pylori infection,
* genetic predisposition (ex: Lynch syndrome),
* MALT lymphoma,
* dyspepsia.
* Subjects affiliated with an appropriate social security system
Exclusion Criteria
* Pregnancy
* Patients receiving proton-pump inhibitors
* Conditions that may interfere with the study objectives according to the investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MATYSIAK BUDNIK Tamara, Pr
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC14_0371
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.